<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0518C2CF-1198-483C-9D01-D6ACE512823A"><gtr:id>0518C2CF-1198-483C-9D01-D6ACE512823A</gtr:id><gtr:name>nanoTherics Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/60559863-9B90-4807-B19C-B9F914E1CF12"><gtr:id>60559863-9B90-4807-B19C-B9F914E1CF12</gtr:id><gtr:name>The Electrospinning Company</gtr:name><gtr:address><gtr:line1>R18 G20 Rutherford Appleton Laboratory</gtr:line1><gtr:line2>Chilton</gtr:line2><gtr:postCode>OX11 0QX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4DE1CF13-63C6-4DDD-B923-74E4F5CC3096"><gtr:id>4DE1CF13-63C6-4DDD-B923-74E4F5CC3096</gtr:id><gtr:name>Aeon Astron B.V.</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/00FE3D00-46A6-4EDB-9672-1565C1E10DB8"><gtr:id>00FE3D00-46A6-4EDB-9672-1565C1E10DB8</gtr:id><gtr:name>Massachusetts Institute of Technology</gtr:name><gtr:address><gtr:line1>77 Massachusetts Avenue</gtr:line1><gtr:postCode>02139</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/58930F3F-9B16-4DC2-833F-C72033E77A1E"><gtr:id>58930F3F-9B16-4DC2-833F-C72033E77A1E</gtr:id><gtr:name>Boston Children's Hospital</gtr:name><gtr:address><gtr:line1>Boston Childrens Hospital</gtr:line1><gtr:line2>Karp Building</gtr:line2><gtr:line3>9th floor, Rm 09210 1 Blackfan Circle</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/445125BE-0D26-4035-9BFE-A99B4F339354"><gtr:id>445125BE-0D26-4035-9BFE-A99B4F339354</gtr:id><gtr:name>UKRMP Acellular Hub and UKRMP Immunomodulation Hub (Delcassian)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FC59975E-26E8-4A62-ABD8-A570DC6ABF06"><gtr:id>FC59975E-26E8-4A62-ABD8-A570DC6ABF06</gtr:id><gtr:name>Keele University</gtr:name><gtr:address><gtr:line1>Keele</gtr:line1><gtr:line4>Newcastle</gtr:line4><gtr:line5>Staffordshire</gtr:line5><gtr:postCode>ST5 5BG</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/70691BB6-0995-4798-B7DC-D767A272C19B"><gtr:id>70691BB6-0995-4798-B7DC-D767A272C19B</gtr:id><gtr:name>Ebers Bioreactors</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/CAA9A40D-0226-4A4F-AC0D-D8299E30A1EF"><gtr:id>CAA9A40D-0226-4A4F-AC0D-D8299E30A1EF</gtr:id><gtr:name>Loughborough University</gtr:name><gtr:department>Wolfson Sch of Mech, Elec &amp; Manufac Eng</gtr:department><gtr:address><gtr:line1>Loughborough University</gtr:line1><gtr:line4>Loughborough</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE11 3TU</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CAA9A40D-0226-4A4F-AC0D-D8299E30A1EF"><gtr:id>CAA9A40D-0226-4A4F-AC0D-D8299E30A1EF</gtr:id><gtr:name>Loughborough University</gtr:name><gtr:address><gtr:line1>Loughborough University</gtr:line1><gtr:line4>Loughborough</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE11 3TU</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0518C2CF-1198-483C-9D01-D6ACE512823A"><gtr:id>0518C2CF-1198-483C-9D01-D6ACE512823A</gtr:id><gtr:name>nanoTherics Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/60559863-9B90-4807-B19C-B9F914E1CF12"><gtr:id>60559863-9B90-4807-B19C-B9F914E1CF12</gtr:id><gtr:name>The Electrospinning Company</gtr:name><gtr:address><gtr:line1>R18 G20 Rutherford Appleton Laboratory</gtr:line1><gtr:line2>Chilton</gtr:line2><gtr:postCode>OX11 0QX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4DE1CF13-63C6-4DDD-B923-74E4F5CC3096"><gtr:id>4DE1CF13-63C6-4DDD-B923-74E4F5CC3096</gtr:id><gtr:name>Aeon Astron B.V.</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/00FE3D00-46A6-4EDB-9672-1565C1E10DB8"><gtr:id>00FE3D00-46A6-4EDB-9672-1565C1E10DB8</gtr:id><gtr:name>Massachusetts Institute of Technology</gtr:name><gtr:address><gtr:line1>77 Massachusetts Avenue</gtr:line1><gtr:postCode>02139</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/58930F3F-9B16-4DC2-833F-C72033E77A1E"><gtr:id>58930F3F-9B16-4DC2-833F-C72033E77A1E</gtr:id><gtr:name>Boston Children's Hospital</gtr:name><gtr:address><gtr:line1>Boston Childrens Hospital</gtr:line1><gtr:line2>Karp Building</gtr:line2><gtr:line3>9th floor, Rm 09210 1 Blackfan Circle</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/445125BE-0D26-4035-9BFE-A99B4F339354"><gtr:id>445125BE-0D26-4035-9BFE-A99B4F339354</gtr:id><gtr:name>UKRMP Acellular Hub and UKRMP Immunomodulation Hub (Delcassian)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC59975E-26E8-4A62-ABD8-A570DC6ABF06"><gtr:id>FC59975E-26E8-4A62-ABD8-A570DC6ABF06</gtr:id><gtr:name>Keele University</gtr:name><gtr:address><gtr:line1>Keele</gtr:line1><gtr:line4>Newcastle</gtr:line4><gtr:line5>Staffordshire</gtr:line5><gtr:postCode>ST5 5BG</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/70691BB6-0995-4798-B7DC-D767A272C19B"><gtr:id>70691BB6-0995-4798-B7DC-D767A272C19B</gtr:id><gtr:name>Ebers Bioreactors</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0375F088-818A-437C-9B0F-0610197366AB"><gtr:id>0375F088-818A-437C-9B0F-0610197366AB</gtr:id><gtr:firstName>Sheila</gtr:firstName><gtr:surname>MacNeil</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A76D16B7-6835-4476-9B66-C5DC92E67A0F"><gtr:id>A76D16B7-6835-4476-9B66-C5DC92E67A0F</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Genever</gtr:surname><gtr:orcidId>0000-0002-5730-8976</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0D887594-55DF-4700-A17C-508595F5727C"><gtr:id>0D887594-55DF-4700-A17C-508595F5727C</gtr:id><gtr:firstName>David John</gtr:firstName><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2DD4AB06-923B-44AF-AA55-1A50255C1FBE"><gtr:id>2DD4AB06-923B-44AF-AA55-1A50255C1FBE</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Fisher</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6390AF4F-E65D-46AF-83DB-A6E00A8FFCE0"><gtr:id>6390AF4F-E65D-46AF-83DB-A6E00A8FFCE0</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Hewitt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8B35A785-A742-4521-AC4C-313107BCC898"><gtr:id>8B35A785-A742-4521-AC4C-313107BCC898</gtr:id><gtr:firstName>Zhongmin</gtr:firstName><gtr:surname>Jin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4A9AA458-F9A0-43EC-9726-86676F718F98"><gtr:id>4A9AA458-F9A0-43EC-9726-86676F718F98</gtr:id><gtr:firstName>Kevin</gtr:firstName><gtr:surname>Shakesheff</gtr:surname><gtr:orcidId>0000-0003-3236-2439</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4A2DC047-DB99-4BE7-BE2B-4BD478404BB6"><gtr:id>4A2DC047-DB99-4BE7-BE2B-4BD478404BB6</gtr:id><gtr:firstName>Alicia</gtr:firstName><gtr:surname>El Haj</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FI017801%2F1"><gtr:id>94019E60-7222-4EAE-B5EC-1387F02CEAA1</gtr:id><gtr:title>E-TERM, Engineering Tissue Engineering and Regenerative Medicine</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/I017801/1</gtr:grantReference><gtr:abstractText>Continued improvement in the nation's health depends upon the efficient development of affordable replacement human tissue and related therapies; an acute shortage of willing organ donors and the shortcomings of conventional therapies leads to the preventable death of many patients each year. The next healthcare revolution will apply regenerative medicines, creating biological therapies or substitutes for the replacement or restoration of tissue function lost through failure or disease. However, whilst science has revealed the potential, and early products have shown the power of such therapies, there is now a need for the long term supply of people properly trained with the necessary skills to lead the engineering and life science challenges before the predicted benefits in human healthcare can be realised. Realisation of these benefits requires a new generation of translational professional leaders immersed in both the fundamental science of these new products and the clinical, engineering and commercial realities of their creation and application.This proposal brings together for the first time the six University teams, and the associated growing cohorts of young researchers, involved in the two Regenerative Medicine DTCs funded through the EPSRC Life Sciences Interface Programme. Each University group is independently internationally leading in their field, and has attracted significant funding from the EPSRC Life Sciences Interface Programme and elsewhere. The proposed Landscape Award offers the opportunity to combine the research strengths of the six groups to deliver a strategic collaborative programme of cross-disciplinary research, and a cohort of future research leaders in tissue engineering and regenerative medicine. The proposed research programme is truly cross-disciplinary, requiring expertise that ranges from fundamental cell biology, through biological engineering, biomechanics and tissue engineering, to bioprocessing, regulated manufacturing, and commercialisation.</gtr:abstractText><gtr:potentialImpactText>Undertaking and ensuring impact activities is integral to the vision and operational processes of the academic groups. We are fortunate that the research portfolios at each of the six universities are user-driven, and in many cases industry led - the focus is on a balance between academic excellence and early industrial relevance. Both DTCs, the Loughborough-led EPSRC Centre for Innovative Manufacturing in Regenerative Medicine, and the Leeds based IKC in Regenerative Therapies and Devices all have established strategies, mechanisms and expert staff for the exploitation of research. The effectiveness of these exploitation strategies is illustrated by the growing number of products and spin-out companies associated with the academic partners. It is our belief and intention that all team members participate in assisting impact. The teams involved in both DTCs have wide experience of managing large and high profile projects and in undertaking impact activities and knowledge transfer at all levels and stakeholder targets. The Landscape Award proposed here has three fundamental deliverables, each of which has highly significant impact across a range of beneficiaries: - a programme of fundamental cross-disciplinary research in tissue engineering and regenerative medicine (TERM) that addresses technological challenges in the translation of promising science to practical therapeutics. Here the impact is geared toward the realisation of regenerative medicine as a viable and wealth-creating industry, the provision of new therapies for use by clinicians, and the promise for patients of new treatments for currently unmet and prevalent chronic conditions. -the identification and nurturing of future research leaders in TERM capable of ensuring the delivery of the potential of RM be this in industry, the public sector, or in academia. -the establishment of a new collaborative research environment between six world leading UK groups based in UK Universities in the fields of tissue engineering and regenerative medicine. Such collaboration will catalyse and accelerate new and ground-breaking advances in both fundamental understanding, and in the translation of that knowledge into everyday healthcare practice. The Landscape Executive Group will regularly review impact made, and the efforts by all associated with the two DTCs to achieve impact. All Fellows projects will have a potential impact analysis and action plan for its execution, and Fellows will receive training as needed to ensure they have the relevant skills. Importantly, as impact activities are an integral part of the working of the two DTCs academic partners, no significant additional financial resource is required.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2884738</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>Through collaboration with a graphics designer, Sarah Bates, Leeds College of Art, we created videos from gene array data to represent the data to the general public in a more engaging manner.</gtr:description><gtr:id>C20ABE6E-6E00-4882-B77E-B5BC3E850A2B</gtr:id><gtr:impact>From the creative representation of the data we were able to pull out analyses not previously seen through traditional methods.</gtr:impact><gtr:outcomeId>56b9d955906651.65957271</gtr:outcomeId><gtr:title>Videos representing Big Data</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boston Children's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Nottingham-MIT-Boston Children's Hospital- Harvard Medical School- Delcassian JDRF secondment</gtr:description><gtr:id>FB1681B8-9E2A-4B89-B055-8EA8A6FAD06C</gtr:id><gtr:impact>This collaboration has just initiated, expected outputs include publications. This project is multidisicplinary, using chemistry, biology, transplant surgery and diabetes related in vivo models .</gtr:impact><gtr:outcomeId>58ac6e2ad4ee12.91906433-2</gtr:outcomeId><gtr:partnerContribution>Dr. Delcassian has taken a 12 month secondment during her E-TERM Fellowship, from March 2017-March 2018, to undertake a new position with Boston Children's Hospital and Harvard Medical School. This role sees her leading a Juvenile Diabetes Research Foundation grant and project in the labs of Prof. Dan Anderson and Prof. Bob Langer, and involves co-managing a team of 10 researchers and technicians working on encapsulated cell therapies for Diabetes-1. The work closely aligns with her own research interests to direct immune behaviour in transplant therapies, and is in collaboration with a number of leading Diabetes research groups.</gtr:partnerContribution><gtr:piContribution>Dr. Delcassian has taken a 12 month secondment during her E-TERM Fellowship, from March 2017-March 2018, to undertake a new position with Boston Children's Hospital and Harvard Medical School. This role sees her leading a Juvenile Diabetes Research Foundation grant and project in the labs of Prof. Dan Anderson and Prof. Bob Langer, and involves co-managing a team of 10 researchers and technicians working on encapsulated cell therapies for Diabetes-1. The work closely aligns with her own research interests to direct immune behaviour in transplant therapies, and is in collaboration with a number of leading Diabetes research groups.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts Institute of Technology (MIT)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Koch Institute</gtr:department><gtr:description>Nottingham-MIT-Boston Children's Hospital- Harvard Medical School- Delcassian JDRF secondment</gtr:description><gtr:id>30C43AEE-0BDB-40C7-A906-245CED61925A</gtr:id><gtr:impact>This collaboration has just initiated, expected outputs include publications. This project is multidisicplinary, using chemistry, biology, transplant surgery and diabetes related in vivo models .</gtr:impact><gtr:outcomeId>58ac6e2ad4ee12.91906433-1</gtr:outcomeId><gtr:partnerContribution>Dr. Delcassian has taken a 12 month secondment during her E-TERM Fellowship, from March 2017-March 2018, to undertake a new position with Boston Children's Hospital and Harvard Medical School. This role sees her leading a Juvenile Diabetes Research Foundation grant and project in the labs of Prof. Dan Anderson and Prof. Bob Langer, and involves co-managing a team of 10 researchers and technicians working on encapsulated cell therapies for Diabetes-1. The work closely aligns with her own research interests to direct immune behaviour in transplant therapies, and is in collaboration with a number of leading Diabetes research groups.</gtr:partnerContribution><gtr:piContribution>Dr. Delcassian has taken a 12 month secondment during her E-TERM Fellowship, from March 2017-March 2018, to undertake a new position with Boston Children's Hospital and Harvard Medical School. This role sees her leading a Juvenile Diabetes Research Foundation grant and project in the labs of Prof. Dan Anderson and Prof. Bob Langer, and involves co-managing a team of 10 researchers and technicians working on encapsulated cell therapies for Diabetes-1. The work closely aligns with her own research interests to direct immune behaviour in transplant therapies, and is in collaboration with a number of leading Diabetes research groups.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Nottingham-MIT Delcassian Collaboration</gtr:description><gtr:id>B399218E-D25F-4D09-B77B-2A14ADA6A233</gtr:id><gtr:impact>This is a multidisciplinary award, focusing on immunology, engineeing, biomaterials fabrication and characterisation, chemistry. It is too early to describe outcomes.</gtr:impact><gtr:outcomeId>56d491f97c83e1.97428434-1</gtr:outcomeId><gtr:partnerContribution>Materials fabricated by Nottingham are being studied in vivo in appropriate diabetes mouse models.</gtr:partnerContribution><gtr:piContribution>Immunmodulatory materials for controlled release of pharmaceuticals have been made by Derfogail Delcassian at Nottingham.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Keele University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Visit to The University of Keele</gtr:description><gtr:id>F358A7EF-9486-4FAC-9ADB-774DD08E80A8</gtr:id><gtr:outcomeId>b970526ab970527e-1</gtr:outcomeId><gtr:piContribution>Short Visit at The University of keele for exploring the use of a Hydrostatic Bioreactor</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Immunology and Immunotherapy</gtr:department><gtr:description>Loughborough - University of Birmingham partnership</gtr:description><gtr:id>8A0F1D36-71DA-48C0-B5F4-1345B577FAB1</gtr:id><gtr:impact>Continued collaboration and research outputs with Prof. Liam Grover

Further collaborations initiated with junior lecturer, Dr. Sophie Cox and Royal Society of Engineering Fellow, Dr. Pola Oppenheimer.

MRC Confidence in Concept research grant for pre-translation of Dr. Davies' EPSRC E-TERM project - &amp;pound;75,000
Finalist at the Enterprising Birmingham Innovation 'most innovative idea' award - final pitch to take place on March 29th 2017</gtr:impact><gtr:outcomeId>58bd9843afb094.57904990-1</gtr:outcomeId><gtr:partnerContribution>Partners provide in kind funding and unlimited access to research facilities.</gtr:partnerContribution><gtr:piContribution>Dr. Davies was invited to the University of Birmingham as an honorary visiting fellow by Professor Liam Grover at the School of Chemical Engineering.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UKRMP Acellular Hub and UKRMP Immunomodulation Hub (Delcassian)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UKRMP Delcassian Immuno-Acellular Hub to Hub Collaboration</gtr:description><gtr:id>90C8D5B6-727F-4C8A-B9C0-2EFDE9A3366E</gtr:id><gtr:impact>This collaboration is mutlidisciplinary, including engineering of immunomodulatory materials (Nottingham) and biological testing of immunomodulatory materials in mouse models (Kings College London). It is too early for outputs/outcomes.</gtr:impact><gtr:outcomeId>56d4904356ce57.82253088-1</gtr:outcomeId><gtr:partnerContribution>The KCL/UKRMP Immunomodulatory Hub (led by Raul Elgueta/Giovanni Lombardi) test materials in mouse models (ie. skin graft) attempting to prolong graft survival.</gtr:partnerContribution><gtr:piContribution>Derfogail Delcassian (E-TERM at Nottingham/UKRMP Acellular Hub) fabricates immunomodulatory biomaterials in controlled release matricies for testing with KCL/UKRMP Immunmodulatory Hub.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts Institute of Technology (MIT)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Nottingham-MIT Delcassian Collaboration</gtr:description><gtr:id>7EE3C69E-B61D-4E8F-A04B-88B138F99C8F</gtr:id><gtr:impact>This is a multidisciplinary award, focusing on immunology, engineeing, biomaterials fabrication and characterisation, chemistry. It is too early to describe outcomes.</gtr:impact><gtr:outcomeId>56d491f97c83e1.97428434-2</gtr:outcomeId><gtr:partnerContribution>Materials fabricated by Nottingham are being studied in vivo in appropriate diabetes mouse models.</gtr:partnerContribution><gtr:piContribution>Immunmodulatory materials for controlled release of pharmaceuticals have been made by Derfogail Delcassian at Nottingham.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>nanoTherics Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Industrial collaboration - nanoTherics</gtr:description><gtr:id>583EF9BB-4121-461A-BA53-DAC08810633B</gtr:id><gtr:impact>The possibility of a patent for the prototype device was explored, and it was decided that an existing patent owned by the company (nanoTherics Ltd) would cover the modifications in the prototype tested. Further device modifications have been discussed, and new prototypes designed, with a view to future collaborative testing in the host laboratory (Dr Divya Chari, Keele University).
This project was multidisciplinary, involving:
Tissue/genetic engineering (cell culture and transfection; Dr S Jenkins, Keele).
Neuroscience (advice on neural cell transplantation populations/procedures; Dr S Jenkins, Dr D Chari, Keele).
Molecular biology (optimisation of plasmid DNA preparations for transfection; Dr A Fernandes, Keele).
Biophysics (interactions between magnetic nanoparticles and magnetic arrays, informing device operation; Prof J Dobson, University of Florida; C Jones, M Subramanian, nanoTherics).
Materials chemistry (informing magnetic nanoparticle selection/design and protocols; Dr H Yiu, University of Edinburgh).</gtr:impact><gtr:outcomeId>545cc7e9edd083.85300226-1</gtr:outcomeId><gtr:partnerContribution>Loan of prototype transfection device (motorised magnetic array designed to enhance magnetic nanoparticle-mediated gene delivery to cell transplant populations). Discussions and expertise on magnetics and biophysics, informing the design of experimental protocols.</gtr:partnerContribution><gtr:piContribution>I have tested the transfection (gene delivery) efficacy of a prototype device, loaned from nanoTherics Ltd. Various vectors, programs and neural cell transplant populations were tested. A report was produced for the company, and following clarification that the prototype device design is covered by patent, the data are being prepared for publication.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ebers Bioreactors</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Short Placement at Ebers Bioreactors</gtr:description><gtr:id>0AFDC24E-C309-4191-AB4D-5B766350D131</gtr:id><gtr:outcomeId>b971bce0b971bcfe-1</gtr:outcomeId><gtr:piContribution>Short placement at Ebers Bioreactors in Zaragoza (Spain) exploring the use of new bioreactor technology</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Aeon Astron B.V.</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Aeon Astron Industrial visit</gtr:description><gtr:id>E3D703D1-0404-4569-9D16-AD5FD2E4DB90</gtr:id><gtr:impact>Strengthening of existing collaboration
Knowledge transfer
Supply of Ologen matrix</gtr:impact><gtr:outcomeId>b9d8b2bab9d8b2ce-1</gtr:outcomeId><gtr:partnerContribution>I received technical assistance regarding protocols and procedures required for working with Ologen collagen matrix and was involved in meetings where the routes and barriers to marketing a product were discussed. It bought up some important considerations for the future regarding bio burdens and regulatory hurdles.</gtr:partnerContribution><gtr:piContribution>5 day industrial outcome to Aeon Astron in Ledien, Holland to engage in knowledge transfer regarding the regulatory hurdles associated with getting regenerated products to market. In addition, discussion of the use of Ologen collagen matrix, a matrix originally developed for skin models, as a potential corneal substrate. A visit intended to facilitate the the development of pipeline technologies by initiating a collaborative relationship.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Electrospinning Company</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Industrial Placement at The Electrospinning Company</gtr:description><gtr:id>DC9E88CA-F743-4D62-A8AF-CE3F846F5EE7</gtr:id><gtr:outcomeId>b9722a68b9722a7c-1</gtr:outcomeId><gtr:piContribution>Industrial placement at The Electrospinning Company (Oxford) exploring scaling-up procedures</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts Institute of Technology (MIT)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>MIT ETERM collaboration</gtr:description><gtr:id>DE8C5955-AF0C-491C-86D4-2DA8979140CD</gtr:id><gtr:impact>Two published journal papers (Biomaterials 2015, COSSMS review 2016). 
One patent application filed (Nottingham, Sept. 2014).</gtr:impact><gtr:outcomeId>542d76e87b74f3.03261927-1</gtr:outcomeId><gtr:partnerContribution>MIT have hosted Asha within their lab, with access to equipment and mentorship. The close collaboration will immerse her in the culture that has made MIT one of the best institutions for translational research. The collaboration will hopefully create a bridge for continued research opportunities beyond my project.</gtr:partnerContribution><gtr:piContribution>We have developed the research proposal. We will contribute scientific understanding of the biomaterial interface with clinically relevant cell types. 
The collaboration strengthens an existing partnership between University of Nottingham and MIT.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Schools Visit - St Peter's School Stargazing Live</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5170557B-2F8E-404F-B169-BCD3C592A6FF</gtr:id><gtr:impact>An interactive exhibition on Stem Cells and the research into their use in regenerative medicine to reduce the number of total joint replacements. We spoke to pupils engaging them in biological research and to the general public, to explain the hope v's hype of stem cell treatments. We were invited to exhibit after being seen at YorNight and have been asked to help with future events to strengthen the relationship between the school and Biology at the University of York.</gtr:impact><gtr:outcomeId>56b9d7b22d1f45.23784220</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.stpetersyork.org.uk/st_peters/news_calendar/news/1672_stargazing_live_2016</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>YorNight Exhibition - 'A joint Endeavour'</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>377720B2-2D0B-4916-8628-7F30DD05BE99</gtr:id><gtr:impact>Interactive exhibition stand as part of European Researchers Night event YorNight. The event was held at various venues across the city, with an estimated attendance of 6000. Our exhibition was a collaboration between the Genever research group at the University of York and Sarah Bates a Graphic Designer studying an MA at Leeds School of Art. Sarah presented large data sets visually through posters and videos. The event as a whole raised the awareness of women in science and the importance of the research York scientists perform.</gtr:impact><gtr:outcomeId>56b9d691806129.62560258</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://yornight.com/2015/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference - Stem Cells in Regenerative Medicine</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>89DFC866-0523-4B5C-9CD4-DA72A93E657E</gtr:id><gtr:impact>Stem Cells in Regenerative Medicine - Oswestry Seminar</gtr:impact><gtr:outcomeId>56b9dac3553d12.82051201</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Schools Talk - Ashton Sixth Form College - Studying a Year in Industry at Univeristy</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3E9E160B-92C0-4EA3-9A0B-F09E0A4568AD</gtr:id><gtr:impact>Three presentations were delivered to Sixth form students at Aston Sixth Form college on Year in industry programmes whilst at University. The talks also focused on Careers in STEM and my own personal experience of gaining industrial experience. The talk sparked questions from students who had not previously thought about a year in industry during a degree.</gtr:impact><gtr:outcomeId>56b9d879ed3a45.67950661</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>E-TERM Translating hMSCs into Therapies Workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2116CEE1-6D2B-4C42-AF95-1642B6D16E74</gtr:id><gtr:impact>The workshop, organised by E-TERM Fellow Qasim Rafiq, had over 50 delegates from the UK, EU and US and generated significant discussion around the issues pertaining to translation of human mesenchymal stem cell (hMSC) therapies, highlighting not only the fundamental biology, but also the technical, commercial and clinical challenges. The intention from the outset was to make this workshop discursive where the format was such that following two keynote talks by eminent academics and industrialists, hour-long interactive sessions would ensue providing an opportunity for all delegates to engage, question and discuss topics relevant to them and the issues at hand. 

6 keynote talks were organised focusing on the biological, manufacturing, commercialisation and clinical challenges and keynote speakers included Dr Robert Deans (Exec VP Athersys), Dr Brian Hampson (VP PCT), Dr Natalie Mount (Chief Clinical Officer, Cell Therapy Catapult), Dr Karen English (NUI Maynooth), Prof. Frank Barry (NUI Galway) and Prof. David Williams (Loughborough University).

Discussions and topics that would never normally have arisen in a traditional conference setting were explored in some depth with potentially significant outputs. During the course of a discussion on serum-free medium, a key outcome was the development of an academic consortium to arrange the bulk purchase of SFM for academic groups at reduced rates</gtr:impact><gtr:outcomeId>54647db4745550.61443044</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.epsrc-regen-med.org/news/review-of-the-recent-translating-mscs-into-therapies-workshop/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference - EuroCell Meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>284FE694-A314-4D63-B400-CD1D42718EDF</gtr:id><gtr:impact>Eurocell Meeting - 2nd International Technical Meeting - Processing Challenges in ACI</gtr:impact><gtr:outcomeId>56b9da8083dcc8.72716544</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New technique may help damaged eyes regain their sight</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DB7E3694-8AA1-4906-8476-451CB805A4EE</gtr:id><gtr:impact>Press release describing progress to date of one of the techniques used in this grant.

Public awareness of this research increased.</gtr:impact><gtr:outcomeId>r-1073858310.53728080c0bb482</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ETERM Tissue Engineering and Regenerative Medicine OUTREACH workshop</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8ABB5918-6CBE-4E41-892A-58EE768FB4B1</gtr:id><gtr:impact>2x 1hr outreach session to lower 6th form students (age 16) at Brine Leas, Nantwich.

2x 1hr Tissue Engineering and Outreach sessions delivered to 11 and 14 A-level (age 16) students respectively. Included introduction of &amp;quot;Tissue engineer&amp;quot; terminology that tied in with the Key Stage 5 National Curriculum. Covered stem cells, what they they are capable of and what we are currently able to do with them. Included multiple interactive/debate sessions when covering the ethics of using stem cells.

Pupils enthused about science education.</gtr:impact><gtr:outcomeId>r-5396543271.2776060ca88384</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Engagement Activity - Royal Society Summer Science Exhibition</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9147B6C3-FB80-42AF-9C54-F879E0D20459</gtr:id><gtr:impact>Team led by Kevin Shakesheff designed and delivered the Biology Builders exhibition during the week-long summer science exhibition.

Engagement of school age learners from across the UK. Engagement of VIPs during evening soiree, including scientific TV personalities.</gtr:impact><gtr:outcomeId>544fae74ca5734.99359438</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.epsrc-regen-med.org/biologybuilders/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pint of Science Outreach Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>66EF18E2-1927-47F3-ACE6-4BC35CCEC560</gtr:id><gtr:impact>Each venue in York attracted 30-40 members of the public. In total over the 3 evenings and 4 streams there were over 300 attendees. The festival informed the public about the research that is being undertaken at the University of York and promoted discussions in an informal and relaxed environment.

On a local scale in York the event received high press coverage in the form of numerous radio interviews and newspaper articles. Attendees highly praised the events and requested future events of this nature, covering a wider range of research activities. Pint of Science was used as a case study in the successful bid from the University of York to host the international researchers night in 2014 and 2015.</gtr:impact><gtr:outcomeId>5425748898d018.64186850</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.pintofscience.com/</gtr:url><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Coffee and Careers Seminars</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BBBDE109-5EB2-4FF1-AB49-D77642BAA2D5</gtr:id><gtr:impact>A monthly seminar for Postgraduate Researchers, Post-Docs and Technical Staff in the Department of Biology, University of York. Each month a careers talk is given by an individual with a PhD (usually Alumni) about their career path to date with advice to participants on how to enter this career. Participants comment on their understanding of future career paths and how to get into them.</gtr:impact><gtr:outcomeId>56b9db8ddd3b75.31988193</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Sheffield Children Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D2E81920-F47A-4777-93B5-D62DA61E76EA</gtr:id><gtr:impact>Interactive stand for children and parents.

Visitors expressed interest in science and research</gtr:impact><gtr:outcomeId>r-9810813795.5989820c066de2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference - Mercia Stem Cell Alliance</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7BCC2078-7356-45AD-9694-3FF71626FD95</gtr:id><gtr:impact>Mercia Stem Cell Alliance Annual Meeting</gtr:impact><gtr:outcomeId>56b9d9ff7999f8.32770859</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>US Cell Therapy Site Visits</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>903B3FC8-8F58-4849-9F0B-2689DD4152C4</gtr:id><gtr:impact>E-TERM Fellow Qasim Rafiq (QR) led a group of 3 PhD students to visit 3 different companies (PCT, Celgene and Irvine Scientific), and incorporated 4 different sites (2 PCT sites, in Mountain View and Allendale). At each company, QR presented an overview of the cell therapy work conducted at Loughborough and more specifically by QR.

Specific outcomes have included:

PCT funding a CDT Regenerative Medicine (Loughborough) studentship on T-cell therapies
PCT hiring a CDT Regenerative Medicine graduate
A signed MOU with Irvine Scientific and significantly reduced rates for Irvine's serum-free medium.</gtr:impact><gtr:outcomeId>54647ff32079a0.96342138</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>96551</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Impact Acceleration account</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>6D1AA2E1-69FD-4CE6-ADA7-13AFE44D602E</gtr:id><gtr:outcomeId>56d4304c096da3.52016796</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2900</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Daniel Turnberg Travel Fellowship Scheme</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>6E7560B6-1EAF-4527-B506-CE72788675AC</gtr:id><gtr:outcomeId>58b7f3a206da44.02911147</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>TCES travel award</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>TC Education Services</gtr:fundingOrg><gtr:id>1B5511FD-18F3-44C5-AB0E-13F58E42143E</gtr:id><gtr:outcomeId>r-6460735291.67169306896cdc</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MEIbioeng15 conference registration bursary</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>MEIbioeng 16</gtr:fundingOrg><gtr:id>02795017-8747-416B-BA43-AD8C649F04CA</gtr:id><gtr:outcomeId>56d4324c6664a4.21389220</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>51402</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Impact Acceleration Account, University of Nottingham. An innovative strategy for vision regeneration using a transplantable tissue-engineered corneal construct</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>FBC808E1-E3DD-4DA4-B765-4A8ADBB881A5</gtr:id><gtr:outcomeId>542430359575e2.84293808</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4000</gtr:amountPounds><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>The Development of a novel human corneal substitute using Ologen Collagen Matrix, Industrial translational funding from Aeon Astron, Europe</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Aeon Astron B.V.</gtr:fundingOrg><gtr:id>A373209F-BA5A-48A8-B59D-4FBBC9C5D64D</gtr:id><gtr:outcomeId>543fa5cc0328c4.64271663</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500</gtr:amountPounds><gtr:country>Belgium, Kingdom of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Joining Forces in Corneal Regeneration Research</gtr:department><gtr:description>Structural analysis and recellularisation of decellularised corneal scaffolds, Short Scientific Mission in collaboration with Trinity college, Dublin as part of the E-COST Action BM-1302, Joining Forces in Corneal Regeneration Research</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>European Cooperation in Science and Technology (COST)</gtr:fundingOrg><gtr:id>7EF3009E-C818-4468-98B6-8DCA5C489F28</gtr:id><gtr:outcomeId>543fa530e8b049.54797529</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>TCES Travel Award</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Tissue and Cell Engineering Society</gtr:fundingOrg><gtr:id>3DB9A66B-BB95-4CA0-8DD9-D41264BFABA7</gtr:id><gtr:outcomeId>54256852693f88.28168695</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4000</gtr:amountPounds><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Industrial Sponsorship</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Aeon Astron B.V.</gtr:fundingOrg><gtr:id>FA8E6B11-14BE-4280-BB80-21B128ABBDCC</gtr:id><gtr:outcomeId>54243096932430.44050554</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>74743</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Confidence in Concept</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>University of Birmingham</gtr:fundingOrg><gtr:id>C9FFA952-E56F-461E-A83A-9F3E153AB7FC</gtr:id><gtr:outcomeId>58bd75a5360e45.78539042</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>TCES travel award</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>TC Education Services</gtr:fundingOrg><gtr:id>F6ED4C0B-6C74-48DE-A45A-49F0B7766C59</gtr:id><gtr:outcomeId>5ebf81b65ebf81ca</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HERMES travel award</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>University of Nottingham</gtr:fundingOrg><gtr:id>12319A5B-F137-4488-AD53-48E843DAF8EB</gtr:id><gtr:outcomeId>5ee3021c5ee30230</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>27000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LimbTox: A cornea in a culture dish, as an animal free engineered model for industrial and pre-clinical research</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>University of Nottingham</gtr:fundingOrg><gtr:fundingRef>13b/I9</gtr:fundingRef><gtr:id>630B05EB-8ECE-4564-965A-6B1B6890D629</gtr:id><gtr:outcomeId>r-1085325815.79436160684d92e</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UKRMP Partnership Award- Delcassian Immuno and Acellular Hub to Hub</gtr:description><gtr:fundingOrg>UK Regenerative Medicine Platform</gtr:fundingOrg><gtr:id>B1EE26C8-FCAE-4258-B576-FCD886960094</gtr:id><gtr:outcomeId>56d492f00b48a1.90560987</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>ETERM has now recruited its final four fellows making twelve two year translational fellowships in all. Careful resource management with some re-allocation has allowed two more fellows to be appointed than was initially anticipated. The ETERM Fellows, both current and alumni, published a paper &amp;quot;The early career researcher's toolkit: translating tissue engineering, regenerative medicine and cell therapy products&amp;quot; in 2015 and are holding a major conference in April 2017 with the aim of setting the direction for translational research in ETERM.
Also the fellows each have their own pathways for impact and will also carry the new knowledge and understanding into their future careers. In addition EPSRC and others are improving their approach to the development of independent early career researchers from the learnings from the Landscape Fellowship programme.</gtr:description><gtr:firstYearOfImpact>2015</gtr:firstYearOfImpact><gtr:id>29134DC7-97EA-4365-B616-B3F8A32307F6</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>54522e9012b132.23833115</gtr:outcomeId><gtr:sector>Education,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>A novel biological therapy for hard tissue regeneration with osteoblasts, or osteoblast-like cells, instructed to produce osteogenesis-enhancing extracellular vesicles (EVs) comprising a heterogeneous cargo of biological factors, which can subsequently be isolated and therapeutically administered.

Benefits of the technology
? Enhanced mineral formation rate, quantity, and quality beyond that of the current clinical gold standard, BMP2.
? No risk of phenotypic conversion or teratogenicity upon implantation.
? EV production can be scaled up (unlike autograft).
? EVs present a more holistic biological approach when compared with the current application of hyper-concentrated growth factors (e.g. BMPs). 
? EVs are not subject to the same ethical considerations or government regulations as cell-based therapies.</gtr:description><gtr:grantRef>EP/I017801/1</gtr:grantRef><gtr:id>5804C066-EF37-4DE7-B824-3AA9488CA97E</gtr:id><gtr:impact>The award of an MRC Confidence in Concept grant for pre-translational work.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58bd819e633b75.43130758</gtr:outcomeId><gtr:patentId>ZSR-1016</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Composition and method for bone regeneration</gtr:title><gtr:yearProtectionGranted>2017</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>The two Regenerative Medicine DTC's have been fortunate to secure in collaboration ten, two year, early career fellowships from EPSRC in the E-TERM, Engineering Tissue Engineering and Regenerative Medicine, Landscape Fellowship Programme. These fellowships are intended to develop promising young interdisciplinary research leaders. We have now recruited 10 fellows. Fellows are working on products for ophthalmic use; cartilage, cardiac and neural tissue engineering including spinal cord repair; and immunological, materials, and manufacturing and scale up issues. They are both working as individual independent researchers supported by mentored personal development and working together as a cadre. They also make significant contributions to the DTC's, primarily by the organisation of specialist workshops focussing on timely issues - these have included regulation, pre-clinical models and mesenchymal stem cell technologies.</gtr:description><gtr:exploitationPathways>Fellowships are translational and individual project findings are taken forward by individual fellows via industrial or clinical collaborations. The fellows are working together on a publication summarising successful ways of working, &amp;quot;tricks of the trade&amp;quot;, for engineering-based tissue engineering and regenerative medicine translational research.</gtr:exploitationPathways><gtr:id>78551016-9859-47E0-964E-6FBC7368CF54</gtr:id><gtr:outcomeId>r-4932265034.8136817798456a</gtr:outcomeId><gtr:sectors><gtr:sector>Education,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.epsrc-regen-med.org/research/e-term-fellowships/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A5619BF2-9821-4AD4-92D6-241CCA519A1E</gtr:id><gtr:title>Decentralised manufacturing of cell and gene therapy products: Learning from other healthcare sectors.</gtr:title><gtr:parentPublicationTitle>Biotechnology advances</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b71b7d7025497fdf93c20b63aa89a8dd"><gtr:id>b71b7d7025497fdf93c20b63aa89a8dd</gtr:id><gtr:otherNames>Harrison RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0734-9750</gtr:issn><gtr:outcomeId>5a969d4a48f976.94049536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>698F6032-B944-48E9-8536-161E0825B68A</gtr:id><gtr:title>A fusion of minicircle DNA and nanoparticle delivery technologies facilitates therapeutic genetic engineering of autologous canine olfactory mucosal cells.</gtr:title><gtr:parentPublicationTitle>Nanoscale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/292bebca667ce985800f0dae21421ae0"><gtr:id>292bebca667ce985800f0dae21421ae0</gtr:id><gtr:otherNames>Delaney AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2040-3364</gtr:issn><gtr:outcomeId>5aaaa0d88093b3.90054459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22692D2F-651E-47E5-9086-CBF3277CA645</gtr:id><gtr:title>A potentially scalable method for the harvesting of hMSCs from microcarriers</gtr:title><gtr:parentPublicationTitle>Biochemical Engineering Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd1d26448de7ac90e59532cd8506f6cd"><gtr:id>dd1d26448de7ac90e59532cd8506f6cd</gtr:id><gtr:otherNames>Nienow A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54576c8ee9e678.38281380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FEAE52A-C22B-4D91-8811-FEDA133E9F70</gtr:id><gtr:title>The effect of porosity on cell ingrowth into accurately defined, laser-made, polylactide-based 3D scaffolds</gtr:title><gtr:parentPublicationTitle>Applied Surface Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/235b35bee28521273844213a658bfbdd"><gtr:id>235b35bee28521273844213a658bfbdd</gtr:id><gtr:otherNames>Danilevicius P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>doi_55f977977ec4e6a2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4333D680-4512-4D6B-9A20-61750C793CBD</gtr:id><gtr:title>A microscopic and macroscopic study of aging collagen on its molecular structure, mechanical properties, and cellular response.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ea8c72639436b3b4cb51f7d009086b3"><gtr:id>5ea8c72639436b3b4cb51f7d009086b3</gtr:id><gtr:otherNames>Wilson SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>doi_53d048048621dcfd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0F375F8-C18C-448F-84DD-E405E4218ADD</gtr:id><gtr:title>A defined synthetic substrate for serum-free culture of human stem cell derived cardiomyocytes with improved functional maturity identified using combinatorial materials microarrays.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15f5a65ec20558965fa2d27363b8d946"><gtr:id>15f5a65ec20558965fa2d27363b8d946</gtr:id><gtr:otherNames>Patel AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>56c3ae11749879.71650106</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0F2B23E-7301-4A39-90EB-D4FCB602B89C</gtr:id><gtr:title>Ultrastructural maintenance of decellularized corneas using dextran</gtr:title><gtr:parentPublicationTitle>Acta Ophthalmologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c074b0c6f486d22501a4078c7e495f14"><gtr:id>c074b0c6f486d22501a4078c7e495f14</gtr:id><gtr:otherNames>Lynch A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d42ebb44d571.79433827</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>563EC048-AC13-4432-873B-49EB8CC6BFA7</gtr:id><gtr:title>Influence of Amplitude of Oscillating Magnetic Fields on Magnetic Nanoparticle-Mediated Gene Transfer to Astrocytes</gtr:title><gtr:parentPublicationTitle>Nano LIFE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae950970732f6111f91324fc97bbec88"><gtr:id>ae950970732f6111f91324fc97bbec88</gtr:id><gtr:otherNames>Tickle J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>5451777d660733.33741919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7D8F079-DC23-4424-9F26-0495E2C0EC76</gtr:id><gtr:title>Corneal Decellularization: A Method of Recycling Unsuitable Donor Tissue for Clinical Translation?</gtr:title><gtr:parentPublicationTitle>Current eye research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ea8c72639436b3b4cb51f7d009086b3"><gtr:id>5ea8c72639436b3b4cb51f7d009086b3</gtr:id><gtr:otherNames>Wilson SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0271-3683</gtr:issn><gtr:outcomeId>56d42ebb172214.25994319</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE79045C-D88B-4581-BA31-82E47C25AA82</gtr:id><gtr:title>Correction to Collagen-Poly(N-isopropylacrylamide) Hydrogels with Tunable Properties.</gtr:title><gtr:parentPublicationTitle>Biomacromolecules</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90f179663f1f7b4887865e5b0971a2b8"><gtr:id>90f179663f1f7b4887865e5b0971a2b8</gtr:id><gtr:otherNames>Barnes AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1525-7797</gtr:issn><gtr:outcomeId>585d70a290c941.80928908</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>994E7320-339E-46A8-8037-B92AFF92D028</gtr:id><gtr:title>Challenges in manufacturing an amniotic membrane alternative for corneal regeneration</gtr:title><gtr:parentPublicationTitle>Acta Ophthalmologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b89b8d9dcf3559c428f57329ef909a43"><gtr:id>b89b8d9dcf3559c428f57329ef909a43</gtr:id><gtr:otherNames>WILSON S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_53d06b06b96ed672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A974186-FDAC-4AB6-9059-0B264AFADBFE</gtr:id><gtr:title>PDGF is a potent initiator of bone formation in a tissue engineered model of pathological ossification.</gtr:title><gtr:parentPublicationTitle>Journal of tissue engineering and regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9f96df79a68ee6d459770e6357b6c43"><gtr:id>c9f96df79a68ee6d459770e6357b6c43</gtr:id><gtr:otherNames>Davies OG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6254</gtr:issn><gtr:outcomeId>58bd71679cc6d1.63367836</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>339CD5DB-E61A-4165-B1DE-18B8DF9BB5ED</gtr:id><gtr:title>Development of Multifunctional Magnetic Nanoparticles for Genetic Engineering and Tracking of Neural Stem Cells.</gtr:title><gtr:parentPublicationTitle>Advanced healthcare materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50075dcc013dd7907d725464ae054feb"><gtr:id>50075dcc013dd7907d725464ae054feb</gtr:id><gtr:otherNames>Adams C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2192-2640</gtr:issn><gtr:outcomeId>56ddb4ee51d4b1.93741734</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F2E8AF5-6C1B-42BA-8B64-3BBBCEAB223F</gtr:id><gtr:title>Magnetic nanoparticles for oligodendrocyte precursor cell transplantation therapies: progress and challenges.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular therapies</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bbdfe56c42d174f5073215400f8d7f7"><gtr:id>0bbdfe56c42d174f5073215400f8d7f7</gtr:id><gtr:otherNames>Jenkins SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2052-8426</gtr:issn><gtr:outcomeId>5451777d99bb69.10354597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93675AA7-799E-4E2D-878F-CE3292DE4595</gtr:id><gtr:title>Directing Immune Cell Responses using Nanopatterned Interfaces</gtr:title><gtr:parentPublicationTitle>TISSUE ENGINEERING PART A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c720a3c022689f44883e4c529043468e"><gtr:id>c720a3c022689f44883e4c529043468e</gtr:id><gtr:otherNames>Delcassian D.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1937-3341</gtr:issn><gtr:outcomeId>58ac6ca5ab0036.66209233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13849862-B31E-40C6-8AD0-6FF77C5C378E</gtr:id><gtr:title>Automating decentralized manufacturing of cell &amp;amp; gene therapy products</gtr:title><gtr:parentPublicationTitle>Cell and Gene Therapy Insights</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d2b9ffc72371ff3aac01acd79f7be7f"><gtr:id>0d2b9ffc72371ff3aac01acd79f7be7f</gtr:id><gtr:otherNames>Harrison R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5a969d4a2004d2.18607880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>415F5140-05A8-433C-A005-F05DC52D0977</gtr:id><gtr:title>Development of a microfabricated artificial limbus with micropockets for cell delivery to the cornea.</gtr:title><gtr:parentPublicationTitle>Biofabrication</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a6d95a0765989ef1bb575d8a6d2d38"><gtr:id>29a6d95a0765989ef1bb575d8a6d2d38</gtr:id><gtr:otherNames>Ortega ?</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1758-5082</gtr:issn><gtr:outcomeId>doi_53d04504503a74ba</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>174CAC82-0749-42B5-9383-DDCEEB2A229C</gtr:id><gtr:title>High throughput screening for discovery of materials that control stem cell fate</gtr:title><gtr:parentPublicationTitle>Current Opinion in Solid State and Materials Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d87383292ff314baabba8e48b3e9fc3a"><gtr:id>d87383292ff314baabba8e48b3e9fc3a</gtr:id><gtr:otherNames>Patel A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56cc7d6d60d8f6.18537664</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C50ABE20-3037-4EBF-B491-CBB6F864FA6E</gtr:id><gtr:title>Decentralized manufacturing of cell and gene therapies: Overcoming challenges and identifying opportunities.</gtr:title><gtr:parentPublicationTitle>Cytotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b71b7d7025497fdf93c20b63aa89a8dd"><gtr:id>b71b7d7025497fdf93c20b63aa89a8dd</gtr:id><gtr:otherNames>Harrison RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1465-3249</gtr:issn><gtr:outcomeId>5a2fe6064526e1.91009899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2FE4F37-8CBC-4B8D-B044-820F1088A5DC</gtr:id><gtr:title>Development of Tissue Engineered Limbal Stem Cell Microenvironments for Corneal Repair</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ec24c9e1332a10be722cd56beeeaf7c"><gtr:id>3ec24c9e1332a10be722cd56beeeaf7c</gtr:id><gtr:otherNames>Ilida Ortega Asencio (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_492028762313e309b4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0CA83A4-D921-45D4-8110-8E0ADFCAF8B4</gtr:id><gtr:title>Hydrogels in Cell-Based Therapies</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc7c5cfd5b1a098c6619926658c8f151"><gtr:id>fc7c5cfd5b1a098c6619926658c8f151</gtr:id><gtr:otherNames>Connon, Che J.; Hamley, Ian W.; Hamley, Ian W.; Murphy, William L.; Xu, Bing; Ulijn, Rein; Wright, Bernice; Heilshorn, Sarah; Jones, Roanna; Khutoryanskiy, Vitaliy V.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:isbn>978-1-84973-798-2</gtr:isbn><gtr:outcomeId>i-8190227279.6167323bb87e1a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0F85ED6-341D-4594-9998-8CA46F4EAD8F</gtr:id><gtr:title>Magnetic Nanoparticle-Mediated Gene Delivery to Two- and Three-Dimensional Neural Stem Cell Cultures: Magnet-Assisted Transfection and Multifection Approaches to Enhance Outcomes.</gtr:title><gtr:parentPublicationTitle>Current protocols in stem cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59460f82b4f3c554f1f2872bf40d05e5"><gtr:id>59460f82b4f3c554f1f2872bf40d05e5</gtr:id><gtr:otherNames>Pickard MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1938-8969</gtr:issn><gtr:outcomeId>58985270ba6b88.07513953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74F47226-669B-4890-8CB6-88A8642FCE9B</gtr:id><gtr:title>Endocytotic potential governs magnetic particle loading in dividing neural cells: studying modes of particle inheritance.</gtr:title><gtr:parentPublicationTitle>Nanomedicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e49727ff748632ede352d801ab426ac"><gtr:id>0e49727ff748632ede352d801ab426ac</gtr:id><gtr:otherNames>Tickle JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1743-5889</gtr:issn><gtr:outcomeId>56d4db714d6839.47945424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06305330-1032-45D3-92E1-B73F5045DBC6</gtr:id><gtr:title>Characterisation and evaluation of the impact of microfabricated pockets on the performance of limbal epithelial stem cells in biodegradable PLGA membranes for corneal regeneration</gtr:title><gtr:parentPublicationTitle>Biomater. Sci.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f4c24de7ddbc186d9bf97f1e2c63023"><gtr:id>5f4c24de7ddbc186d9bf97f1e2c63023</gtr:id><gtr:otherNames>Ortega I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>doi_53d03003008d1d27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88F82157-A255-4636-A035-92AD50235E9C</gtr:id><gtr:title>T cell immunoengineering with advanced biomaterials.</gtr:title><gtr:parentPublicationTitle>Integrative biology : quantitative biosciences from nano to macro</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8060ffc4a3f8f0a12c93d102faed289"><gtr:id>f8060ffc4a3f8f0a12c93d102faed289</gtr:id><gtr:otherNames>Delcassian D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1757-9694</gtr:issn><gtr:outcomeId>58ac6d353c4fb6.36474142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18E1729B-B3C5-4F4B-91C7-2E99C6E08AFB</gtr:id><gtr:title>Restoration of keratocyte cell phenotype through epithelial-stromal cell interactions in a 3D hydrogel model</gtr:title><gtr:parentPublicationTitle>Acta Ophthalmologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b89b8d9dcf3559c428f57329ef909a43"><gtr:id>b89b8d9dcf3559c428f57329ef909a43</gtr:id><gtr:otherNames>WILSON S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_53d06b06b97a198b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E3E6BCE-AEA1-43FC-B603-D910AF47CD0B</gtr:id><gtr:title>Dextran Preserves Native Corneal Structure During Decellularization.</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part C, Methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/561a2a4ca76377519bd24b354b406473"><gtr:id>561a2a4ca76377519bd24b354b406473</gtr:id><gtr:otherNames>Lynch AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1937-3384</gtr:issn><gtr:outcomeId>585d4d3491b1d3.15396812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>799D47A3-A681-48BF-9495-76E075E53CA8</gtr:id><gtr:title>Manufacturing of Tissue Engineered Stem Cell Niches for Corneal Healing</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ec24c9e1332a10be722cd56beeeaf7c"><gtr:id>3ec24c9e1332a10be722cd56beeeaf7c</gtr:id><gtr:otherNames>Ilida Ortega Asencio (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>m_898322795713e307de</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9B498EE-2CD3-478B-B078-DF6FF58053FA</gtr:id><gtr:title>Development of Tissue Engineered Limbal Stem Cell Microenvironments for Corneal Repair</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ec24c9e1332a10be722cd56beeeaf7c"><gtr:id>3ec24c9e1332a10be722cd56beeeaf7c</gtr:id><gtr:otherNames>Ilida Ortega Asencio (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>m_286233840613e3059a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C1247CF-2231-4317-99FC-B8F99EFE0ACD</gtr:id><gtr:title>Process development of human multipotent stromal cell microcarrier culture using an automated high-throughput microbioreactor.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ef9ca338c86bf075398ae34005a7645"><gtr:id>2ef9ca338c86bf075398ae34005a7645</gtr:id><gtr:otherNames>Rafiq QA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>5a35196eabd454.55081190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F623EC32-51ED-4175-9518-7133E695D959</gtr:id><gtr:title>Mechanisms of Polymer-Templated Nanoparticle Synthesis: Contrasting ZnS and Au.</gtr:title><gtr:parentPublicationTitle>Langmuir : the ACS journal of surfaces and colloids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b81a16cf511b0aaf6a9f9c4e13d7199"><gtr:id>6b81a16cf511b0aaf6a9f9c4e13d7199</gtr:id><gtr:otherNames>Podhorska L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0743-7463</gtr:issn><gtr:outcomeId>58ac6ca585eed2.10583605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB7EE979-E843-46B3-A91E-8B635E072BB8</gtr:id><gtr:title>'Stealth' nanoparticles evade neural immune cells but also evade major brain cell populations: Implications for PEG-based neurotherapeutics.</gtr:title><gtr:parentPublicationTitle>Journal of controlled release : official journal of the Controlled Release Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bbdfe56c42d174f5073215400f8d7f7"><gtr:id>0bbdfe56c42d174f5073215400f8d7f7</gtr:id><gtr:otherNames>Jenkins SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-3659</gtr:issn><gtr:outcomeId>56d4dab1a5e1b2.20618131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38D4A171-4565-4F97-B814-581C5DC62EA9</gtr:id><gtr:title>Combined microfabrication and electrospinning to produce 3-D architectures for corneal repair.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f4c24de7ddbc186d9bf97f1e2c63023"><gtr:id>5f4c24de7ddbc186d9bf97f1e2c63023</gtr:id><gtr:otherNames>Ortega I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>doi_53cfe2fe21bac7b4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D88F731C-B6CC-4052-9C9F-20822ABE0AE2</gtr:id><gtr:title>Identifying the Cellular Mechanisms Leading to Heterotopic Ossification.</gtr:title><gtr:parentPublicationTitle>Calcified tissue international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9f96df79a68ee6d459770e6357b6c43"><gtr:id>c9f96df79a68ee6d459770e6357b6c43</gtr:id><gtr:otherNames>Davies OG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0171-967X</gtr:issn><gtr:outcomeId>58bd71afe55ac7.41530643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>323C9EED-EA4A-43C5-884A-5F036CE93E55</gtr:id><gtr:title>Microfabrication of Artificial Limbal Stem Cell Microenvironments</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ec24c9e1332a10be722cd56beeeaf7c"><gtr:id>3ec24c9e1332a10be722cd56beeeaf7c</gtr:id><gtr:otherNames>Ilida Ortega Asencio (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>m_437399423713e3089c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B31BB830-9E36-4187-9CC6-5353DB4ADF24</gtr:id><gtr:title>Cultivation and characterisation of human peripheral cornea derived endothelial cells</gtr:title><gtr:parentPublicationTitle>Acta Ophthalmologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ccd1d09b6a4d45834d06adbe5bab830"><gtr:id>6ccd1d09b6a4d45834d06adbe5bab830</gtr:id><gtr:otherNames>ALBERT R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>56d42ebbb5ac70.95564315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F365DB63-CFF1-4BB3-98AD-EAEB56283746</gtr:id><gtr:title>Keeping an eye on decellularized corneas: a review of methods, characterization and applications.</gtr:title><gtr:parentPublicationTitle>Journal of functional biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ea8c72639436b3b4cb51f7d009086b3"><gtr:id>5ea8c72639436b3b4cb51f7d009086b3</gtr:id><gtr:otherNames>Wilson SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2079-4983</gtr:issn><gtr:outcomeId>doi_53d087087dcbcf14</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>953D0FE3-EB7E-4656-92FC-CF84A7BD9F2C</gtr:id><gtr:title>An overview of current techniques for ocular toxicity testing.</gtr:title><gtr:parentPublicationTitle>Toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ea8c72639436b3b4cb51f7d009086b3"><gtr:id>5ea8c72639436b3b4cb51f7d009086b3</gtr:id><gtr:otherNames>Wilson SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-483X</gtr:issn><gtr:outcomeId>54c7a7f6436ab4.82726525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAB1730C-3AAE-4E9F-8F86-8E2EA687FBC5</gtr:id><gtr:title>Development of Tissue Engineered Stem Cell Niches for Corneal Repair</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ec24c9e1332a10be722cd56beeeaf7c"><gtr:id>3ec24c9e1332a10be722cd56beeeaf7c</gtr:id><gtr:otherNames>Ilida Ortega Asencio (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_147945577313e30a72</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB43A21E-E00E-4A51-B2D1-66A5B4FE706F</gtr:id><gtr:title>Nanoengineering neural stem cells on biomimetic substrates using magnetofection technology.</gtr:title><gtr:parentPublicationTitle>Nanoscale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d00751e2e28f2f8377cfe0825d7c894f"><gtr:id>d00751e2e28f2f8377cfe0825d7c894f</gtr:id><gtr:otherNames>Adams CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2040-3364</gtr:issn><gtr:outcomeId>589497b1c9ab19.99829461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A073ACA1-76AA-4A9E-B891-B9DA6FF5AFF5</gtr:id><gtr:title>Collagen-Poly(N-isopropylacrylamide) Hydrogels with Tunable Properties.</gtr:title><gtr:parentPublicationTitle>Biomacromolecules</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90f179663f1f7b4887865e5b0971a2b8"><gtr:id>90f179663f1f7b4887865e5b0971a2b8</gtr:id><gtr:otherNames>Barnes AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1525-7797</gtr:issn><gtr:outcomeId>568a53911df029.32479467</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D215325-4BE5-4A7C-84CC-6C530C03FCAD</gtr:id><gtr:title>Corneal decellularisation: recycling tissue for transplantation</gtr:title><gtr:parentPublicationTitle>Acta Ophthalmologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b89b8d9dcf3559c428f57329ef909a43"><gtr:id>b89b8d9dcf3559c428f57329ef909a43</gtr:id><gtr:otherNames>WILSON S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56d42ebb687b78.27642743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB0DA50B-3913-4F24-A24B-4B0131D94CCC</gtr:id><gtr:title>Drug delivery across length scales.</gtr:title><gtr:parentPublicationTitle>Journal of drug targeting</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8060ffc4a3f8f0a12c93d102faed289"><gtr:id>f8060ffc4a3f8f0a12c93d102faed289</gtr:id><gtr:otherNames>Delcassian D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1026-7158</gtr:issn><gtr:outcomeId>5a9d736bf05e85.41129668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B85FEFAC-6BE2-48FF-9379-54F70C5E1F87</gtr:id><gtr:title>Enhancing cell and gene therapy manufacture through the application of advanced fluorescent optical sensors (Review).</gtr:title><gtr:parentPublicationTitle>Biointerphases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b71b7d7025497fdf93c20b63aa89a8dd"><gtr:id>b71b7d7025497fdf93c20b63aa89a8dd</gtr:id><gtr:otherNames>Harrison RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1559-4106</gtr:issn><gtr:outcomeId>5a352f04848526.65287360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E0EE716-5D55-4307-A9CC-CE93F66627CB</gtr:id><gtr:title>Using a 3-D multicellular simulation of spinal cord injury with live cell imaging to study the neural immune barrier to nanoparticle uptake</gtr:title><gtr:parentPublicationTitle>Nano Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/375d837c22994577a66d8e53a85447e5"><gtr:id>375d837c22994577a66d8e53a85447e5</gtr:id><gtr:otherNames>Weightman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d4d316ed006.35649332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90A400CF-72BF-4D8A-A53A-A5D37D8F687E</gtr:id><gtr:title>Corneal stromal cell plasticity: in vitro regulation of cell phenotype through cell-cell interactions in a three-dimensional model.</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ea8c72639436b3b4cb51f7d009086b3"><gtr:id>5ea8c72639436b3b4cb51f7d009086b3</gtr:id><gtr:otherNames>Wilson SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1937-3341</gtr:issn><gtr:outcomeId>5457826829c8b7.36649233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>189802FB-4C2F-45B2-A117-8D11403D91E6</gtr:id><gtr:title>The early career researcher's toolkit: translating tissue engineering, regenerative medicine and cell therapy products.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ef9ca338c86bf075398ae34005a7645"><gtr:id>2ef9ca338c86bf075398ae34005a7645</gtr:id><gtr:otherNames>Rafiq QA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>568a53914d4a51.41510065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF234E4D-E06A-4AD1-AE4E-47666C3C84B3</gtr:id><gtr:title>Development of Tissue Engineered Microenvironments for Corneal Repair</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ec24c9e1332a10be722cd56beeeaf7c"><gtr:id>3ec24c9e1332a10be722cd56beeeaf7c</gtr:id><gtr:otherNames>Ilida Ortega Asencio (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>m_351404867913e306c6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0705049B-017A-4E35-B066-AFE20A91257A</gtr:id><gtr:title>Development of a nanomaterial bio-screening platform for neurological applications.</gtr:title><gtr:parentPublicationTitle>Nanomedicine : nanotechnology, biology, and medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bbdfe56c42d174f5073215400f8d7f7"><gtr:id>0bbdfe56c42d174f5073215400f8d7f7</gtr:id><gtr:otherNames>Jenkins SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-9634</gtr:issn><gtr:outcomeId>5451777d215491.49790281</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/I017801/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>195B48B4-2BC5-4DEB-BA1A-323A90D8730D</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Tissue engineering</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>